Molecular pharmacology of G protein-coupled receptors. Editorial.
G protein-coupled receptors are the largest group of membrane proteins and are the targets for approximately 30% of drugs currently used therapeutically. These 7-transmembrane-spanning proteins continue to provide new opportunities to develop therapeutics based on emerging knowledge of their structure, signalling properties and interactions with other proteins. This themed issue of the British Journal of Pharmacology contains a series of papers that cover these issues and identify approaches that may determine future directions. Many of these papers contain material that was presented at the 5th International Molecular Pharmacology of G Protein-Coupled Receptors meeting held in Sydney Australia in late 2008.
Summers
R J
RJ
D016503:Drug Delivery Systems; D015195:Drug Design; D006801:Humans; D008024:Ligands; D011487:Protein Conformation; D043562:Receptors, G-Protein-Coupled / Q000737:chemistry / Q000187:drug effects* / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects
D008024:Ligands; D043562:Receptors, G-Protein-Coupled
Br J Pharmacol. 2010 Mar;159(5):997-1008
20136835
Br J Pharmacol. 2010 Mar;159(5):986-96
19912230
Br J Pharmacol. 2010 Mar;159(5):1022-38
20132209
Br J Pharmacol. 2010 Mar;159(5):1059-68
20015292
Br J Pharmacol. 2010 Mar;159(5):1039-50
20136834
Br J Pharmacol. 2010 Mar;159(5):1009-21
19922535
Br J Pharmacol. 2010 Mar;159(5):1051-8
19888962